AI
BSX icon

ArchPoint Investors’s Boston Scientific BSX Stock Holding History

ArchPoint Investors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,200
Closed -$10K – 158
2017
Q4 		$10K Buy
+8,200
New +$226K ﹤0.01% 150

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ArchPoint Investors's BSX Position: Q1 2021 in Review

ArchPoint Investors sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 10,000 shares — an estimated $360K sold.

ArchPoint Investors first reported a position in BSX in Q4 2016 and held it in 17 quarters. The position peaked at $3.6M in Q3 2018. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • ArchPoint Investors reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • ArchPoint Investors sold 10,000 Boston Scientific shares in Q1 2021, an estimated $360K.
  • ArchPoint Investors first reported a position in Boston Scientific in Q4 2016 and held it in 17 quarters.
  • ArchPoint Investors's Boston Scientific position peaked at $3.6M in Q3 2018.
  • 831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on ArchPoint Investors's 13F filing for Q1 2021, filed 13 May 2021.